4 月份,生物科技公司 Vaxxinity Inc. 的空头持仓量有所下降。
In April, Vaxxinity Inc., a biotech firm, saw a decline in short interest.
Vaxxinity Inc. 是一家专注于神经病学、心血管病和冠状病毒的生物科技公司,4 月份其空头持仓量下降了 56.4%,至 184 万股。
Vaxxinity Inc., a neurology, cardiovascular, and coronavirus-focused biotech firm, experienced a 56.4% decline in short interest in April, with 1.84M shares.
其市值为 646 万美元,负债权益比率为 0.99,季度每股收益为 (0.09 美元)。
It has a market cap of $6.46M, a debt-to-equity ratio of 0.99, and reported a Q EPS of ($0.09).
对冲基金 Ieq Capital 持有其 0.07% 的股份,机构投资者持有 Vaxxinity 82.95% 的股份。
Hedge fund Ieq Capital owns 0.07% of its stock, and institutional investors hold 82.95% of Vaxxinity's stock.